Calendrier vaccinal et recommandations actuelles chez les patients atteints de cancer
Innovations & Thérapeutiques en Oncologie · 01.04.2026 · 12 (S1) · 14-18
DOI: 10.1684/ito.2026.569 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovations & Thérapeutiques en Oncologie, erschienen am 01.04.2026. Verfasst von Claire Aguilar.
Abstract (Originalsprache)
Due to immunosuppression and sometimes also due to possible comorbidities, patients receiving treatment for solid cancers require, specific vaccinations to reduce the risk of infection. Live vaccines are contraindicated. Vaccinations against influenza and SARS-CoV-2 are recommended for all patients, as well as vaccination against pneumococcus with the conjugate vaccine, and vaccination against shingles. Certain treatments can reduce the effectiveness of vaccines, to varying degrees. For some conditions (notably respiratory infections), this reinforces the importance of vaccinating the patient’s close contacts, as well as the healthcare professionals involved in the care of these patients.
Zitieren
APA
Aguilar, C. (2026). Calendrier vaccinal et recommandations actuelles chez les patients atteints de cancer. Innovations & Thérapeutiques en Oncologie, 12(S1), 14-18. https://doi.org/10.1684/ito.2026.569
Vancouver
Aguilar C. Calendrier vaccinal et recommandations actuelles chez les patients atteints de cancer. Innovations & Thérapeutiques en Oncologie. 2026;12(S1):14-18. doi:10.1684/ito.2026.569
BibTeX
@article{Aguilar2026,
author = {Aguilar, Claire},
title = {Calendrier vaccinal et recommandations actuelles chez les patients atteints de cancer},
journal = {Innovations & Thérapeutiques en Oncologie},
year = {2026},
volume = {12},
number = {S1},
pages = {14--18},
doi = {10.1684/ito.2026.569}
}
EUVIMED